InvestorsHub Logo
Followers 6
Posts 1089
Boards Moderated 0
Alias Born 07/18/2006

Re: Whalatane post# 17467

Wednesday, 07/17/2024 8:10:46 AM

Wednesday, July 17, 2024 8:10:46 AM

Post# of 17476
Whalatane- Thinking about what you are saying about the apparently prohibitively high (exorbitant) cost of Aurinia's Lupkynis, in your opinion/view is the following hypothetical scenario possible/feasible?

The price of Lupykynis gets cut to the same price as Benlysta (Belimumab), which I believe is essentially a garbage drug compared to voclosporin.
I'm thinking if that happened, the sales of Lupykynis would soar by multiples of what they are currently, since the performance of Benlysta is dramatically inferior.

TIA
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AUPH News